Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Physiol Behav. 2015 Feb 7;148:100–110. doi: 10.1016/j.physbeh.2015.02.013

Table 2.

Results summary for examination of mRNA (Exp 1) and protein (Exp 2) within the nucleus accumbens of rat pups on PD4, 8 or 12 following prenatal exposure to 0, 1 or 2 g/kg EtOH on GD17-20.

Nucleus Accumbens mRNA Protein
PD4 PD8 PD12 PD4 PD8 PD12
MOR 0g/kg
1g/kg
2g/kg
2.62 ± 0.52
2.69 ± 0.36
3.01 ± 0.53
2.33 ± 0.23
2.20 ± 0.18
1.73 ± 0.12
1.60 ± 0.13
1.56 ± 0.06
1.38 ± 0.06
Age: F(2,60)=14.006, p<0.0001
Dose: F(2,60)=0.196, p=.822
Age × Dose: F(4,60)=0.761, p=.555
124858.16 ± 3827.70
107210.42 ± 8433.81
123952.91 ± 3160.56
115867.83 ± 7392.51
115815.40 ± 6803.24
120808.35 ± 6950.47
135626.92 ± 2478.19
127742.67 ± 3277.05
91364.74 ± 4315.04
Age: F(2,68)=0.032, p=.969
Dose: F(2,68)=3.571, p<0.05
Age × Dose: F(4,68)=6.23, p<.0005
POMC / β-endorphin 0g/kg
1g/kg
2g/kg
121.94 ± 41.36
52.91 ± 12.36
214.14 ± 66.49
404.84 ± 124.38
157.24 ± 42.92
118.15 ± 18.24
308.19 ± 54.38
406.20 ± 64.94
385.42 ± 47.08
Age: F(2,58)=11.053, p<0.0001
Dose: F(2,58)=1.066, p=.351
Age × Dose: F(4,58)=3.792, p<0.05
0.112 ± 0.025
0.093 ± 0.017
0.096 ± 0.017
0.082 ± 0.016
0.120 ± 0.019
0.064 ± 0.010
0.070 ± 0.012
0.074 ± 0.012
0.083 ± 0.011
Age: F(2,64)=2.297, p=.109
Dose: F(2,64)=.675, p=.513
Age × Dose: F(4,64)=1.857, p=.129
KOR 0g/kg
1g/kg
2g/kg
2.56 ± 0.29
3.57 ± 0.35
3.44 ± 0.44
3.39 ± 0.44
4.11 ± 0.39
5.92 ± 0.30
4.49 ± 0.28
4.30 ± 0.21
4.04 ± 0.37
Age: F(2,56)=10.577, p<0.0005
Dose: F(2,56)=5.554, p<0.01
Age × Dose: F(4,56)=5.65, p<0.001
100811.18 ± 3915.24
98333.27 ± 3074.02
90815.98 ± 4211.37
96215.92 ± 5799.11
97593.04 ± 2701.47
105432.80 ± 4372.21
104894.08 ± 1299.38
100192.23 ± 2734.94
93432.43 ± 3859.63
Age: F(2,66)=0.631, p=.535
Dose: F(2,66)=0.875, p=.421
Age × Dose: F(4,66)=2.527, p<0.05
PPD / dynorphin 0g/kg
1g/kg
2g/kg
5.04 ± 0.46
7.28 ± 1.20
7.98 ± 0.92
12.72 ± 1.32
12.88 ± 1.34
18.44 ± 2.21
20.98 ± 3.85
21.58 ± 0.82
25.09 ± 3.48
Age: F(2,60)=38.88, p<0.0001
Dose: F(2,60)=3.109, p=052
Age × Dose: F(4,60)=0.315, p=.867
0.968 ± 0.409
1.279 ± 0.310
1.467 ± 0.538
2.287 ± 0.680
0.977 ± 0.283
0.330 ± 0.109
0.689 ± 0.163
0.554 ± 0.283
0.785 ± 0.272
Age: F(2,64)=1.772, p=.178
Dose: F(2,64)=1.134, p=.328
Age × Dose: F(4,64)=2.788, p<0.05
DOR 0g/kg
1g/kg
2g/kg
3.74 ± 0.62
5.92 ± 0.78
6.48 ± 1.22
5.91 ± 0.76
7.50 ± 0.75
7.77 ± 0.75
9.19 ± 1.35
8.01 ± 0.68
9.79 ± 1.68
Age: F(2,59)=9.281, p<0.001
Dose: F(2,59)=2.135, p=.127
Age × Dose: F(4,59)=0.807, p=.523
111173.68 ± 4365.36
96218.83 ± 5441.77
114707.86 ± 6736.15
108291.47 ± 5026.43
118189.99 ± 4077.11
114695.44 ± 5618.89
107695.35 ± 4391.24
105273.05 ± 2840.05
96313.74 ± 2200.25
Age: F(2,65)=3.59, p<0.05
Dose: F(2,65)=0.220, p=.726
Age × Dose: F(4,65)=3.171, p<0.05
PPE / enkephalin 0g/kg
1g/kg
2g/kg
4.63 ± 1.39
5.70 ± 1.25
7.18 ± 0.44
10.78 ± 0.83
10.40 ± 1.93
15.80 ± 1.73
22.64 ± 3.49
25.53 ± 1.72
23.86 ± 4.13
Age: F(2,56)=42.604, p<0.0001
Dose: F(2,56)=1.096, p=.341
Age × Dose: F(4,56)=.570, p=.685
0.039 ± 0.014
0.042 ± 0.009
0.049 ± 0.015
0.053 ± 0.012
0.084 ± 0.019
0.052 ± 0.018
0.147 ± 0.038
0.083 ± 0.026
0.170 ± 0.062
Age: F(2,63)=8.831, p<0.0005
Dose: F(2,63)=.399, p=.672
Age x Dose: F(4,63)1.3063, p=.277

Data represent means and SEM for designated factors. Significant differences from water-intubated controls (i.e., 0 g/kg) are represented by bold font (p<0.05).